Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation

Transplantation

Volumn 92, Issue 2, 2011, Pages 244-250

  Rank, Andreas ^a   Nieuwland, Rienk ^b   Toth, Bettina ^c   Pihusch, Verena ^d   Delker, Ruth ^e   Hiller, Erhard ^a   Kolb, Hans Jochem ^f   Pihusch, Rudolf ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MVZ Pihusch   (Germany)

^e KLINIKUM AUGSBURG   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Erythrocytes; Graft versus host disease; Hematopoietic stem cell transplantation; Infection; Microparticles

Indexed keywords

AMSACRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASIA; ARTICLE; CANCER CHEMOTHERAPY; CENTRIFUGATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG MEGADOSE; ERYTHROCYTE COUNT; ERYTHROCYTE DERIVED MICROPARTICLE; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HUMAN; INFECTION; LYMPHOCYTE DEPLETION; MALE; MEMBRANE MICROPARTICLE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; T LYMPHOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC; ANNEXIN A5; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTES; FEMALE; GLYCOPHORIN; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEPSIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79960336368     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318221d3e9     Document Type: Article

References (40)

1. Diamant M, Tushuizen ME, Sturk A, et al. Cellular microparticles: New players in the field ofvascular disease? Eur J Clin Invest 2004; 34: 392.
2. Van Wijk JM, Nieuwland R, Boer K, et al. Microparticle subpopula-tions are increased in pre-eclampsia: Possible involvement in vascular dysfunction? Am J Obstet Gynecol 2002; 187: 450.
3. Barry OP, Pratico D, Lawson JA, et al. Transcellular activation ofplate-lets and endothelial cells by bioactive lipids in platelet microparticles. JClin Invest 1997; 99: 2118.
4. Barry OP, Pratico D, Savani RC, et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136.
5. Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte mi-croparticles are associated with venous thrombogenesis. J Vasc Surg 2003; 38: 1075.
6. Sellam J, Proulle V, Jüngel A, et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus ery-thematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009; 11: R156.
7. Erdbruegger U, Grossheim M, Hertel B, et al. Diagnostic role ofendo-thelial microparticles in vasculitis. Rheumatology (Oxford) 2008; 47: 1820.
8. Feng B, Chen Y, Luo Y, et al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 2010; 208:264.
9. Kuriyama N, Nagakane Y, Hosomi A, et al. Evaluation of factors associated with elevated levels ofplatelet-derived microparticles in the acute phase of cerebral infarction. Clin Appl Thromb Hemost 2010; 16: 26.
10. Li X, Cong H. Platelet-derived microparticles and the potential ofgly-coprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J 2009;36: 134.
11. Kaptan K, Beyan C, Ifran A, et al. Platelet-derived microparticle levels in women with recurrent spontaneous abortion. Int JGynaecol Obstet 2008; 102: 271.
12. Toth B, Liebhardt S, Steinig K, et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008; 100:663.
13. Chironi G, Simon A, Hugel B, et al. Circulating leukocyte-derived mi-croparticles predict subclinical atherosclerosis burden in asymptom-atic subjects. Arterioscler Thromb Vasc Biol 2006; 26: 2775.
14. Kelton JG. Heparin-induced thrombocytopenia: An overview. Blood Rev 2002; 16: 77.
15. Allan D, Thomas P. Ca21-induced biochemical changes in human erythrocytes and their relation to microvesiculation. Biochem J 1981; 198: 433.
16. Greenwalt TJ. The how and why ofexocytic vesicles. Transfusion 2006; 46: 143.
17. Nieuwland R, Berckmans RJ, Mc Gregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95:930.
18. Mostefai HA, Meziani F, Mastronardi ML, et al. Circulating micropar-ticles from patients with septic shock exert protective role in vascular function. Am JRespir Crit Care Med 2008; 178: 1148.
19. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial micro-particles are associated with vascular dysfunction in patients with end-stage renal failure. JAm Soc Nephrol 2005; 16: 3381.
20. van Beers EJ, Schaap MC, Berckmans RJ, et al. CURAMA studygroup. Circulating erythrocyte-derived microparticles are associated with co-agulation activation in sickle cell disease. Haematologica 2009; 94:1513.
21. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362.
22. Rubin O, Crettaz D, Canellini G, et al. Microparticles in stored red blood cells: An approach using flow cytometry and proteomic tools. Vox Sang 2008; 95: 288.
23. Rank A, Nieuwland R, Crispin K, et al. Clearance ofplatelet micropar-ticles invivo. Platelets 2011; 22: 111.
24. Martí-Lliteras P, Regueiro V, Morey P, et al. Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun 2009; 77: 4232.
25. Willekens FL, Werre JM, Kruijt JK, et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scaven-ger receptors. Blood 2005; 105: 2141.
26. Paczesny S, Hanauer D, Sun Y, et al. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010; 45: 1.
27. Holler E, Kolb HJ, Möller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011.
28. Sale GE, Lerner KG, Barker EA, et al. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol 1977; 89: 621.
29. Beschorner WE, Pino J, Boitnott JK, et al. Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. Am J Pathol 1980; 99:369.
30. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964.
31. Holler E. Cytokines, viruses and graft-versus-host disease. Curr Opin Hematol 2002; 9: 479.
32. Lok CA, Van Der Post JA, Sargent IL, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008; 27: 344.
33. Cudihy D, Lee RV. The pathophysiology of pre-eclampsia: Current clinical concepts. J Obstet Gynaecol 2009; 29: 576.
34. Pihusch V, Rank R, Steber R, et al. Endothelial cell derived micropar-ticles in allogeneic hematopoietic stem cell recipients. Transplantation 2006; 81: 1405.
35. Ruutu T, Barosi G, Benjamin RJ, et al. Diagnostic criteria for hemato-poietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group. Haematologica 2007; 92:95.
36. André Tichelli, Alois Gratwohl. Vascular endothelium as 'novel' target ofgraft-versus-hostdisease. Best Pract Res Clin Haematol 2008; 21:139.
37. Rank A, Nieuwland R, Delker R, et al. Surveillance ofmegakaryocytic func-tion by measurement of CD61-exposing microparticles in allogeneic he-matopoietic stem cellrecipients. Clin Transplant 2011; 25: e233.
38. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations ofgraft-versus-host disease in human recipients of marrow from HLA-matched siblingdonors. Transplantation 1974; 18: 295.
39. Berckmans RJ, Nieuwland R, Böing A, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin genera-tion. Thromb Haemost 2001; 83:639.
40. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highlyprocoagulant. Circulation 1997; 96: 3534.